WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2025ACC: 0001415889-25-005357
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-35.13K
Net shares
Net seller
$339.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
35.13K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−35.13K
Price / share
$9.66
Trade value
$339.35K
% of position
1.9%
2/20/2025
1.81M→1.78M
Total
Net shares
−35.13K
Net value
-$339.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2025 | F · Tax Withholding | −35.13K | $9.66 | $339.35K | 1.9% | 1.81M | 1.78M |
| Total | −35.13K | -$339.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned92.57K
Ordinary Shares
IndirectShares owned3.90K
Total
96.47K indirect96.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Ordinary Shares | 3.90K | Indirect |
| Total | 96.47K | 96.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported